Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Weight loss drugs Ozempic and Wegovy would no longer be covered by California's health insurance for low-income people under ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...